Home » Eisai, TorreyPines to Collaborate in Alzheimer's Drug Development
Eisai, TorreyPines to Collaborate in Alzheimer's Drug Development
March 18, 2005
Eisai announced on March 18 that the company has concluded an agreement with
TorreyPines Therapeutics to collaborate in new drug development. Under the terms
of the agreement, the two companies aim to develop a disease modifying agent
for patients with Alzheimer's disease. Eisai will receive rights of first negotiation
and refusal for new compounds identified by TorreyPines Therapeutics. If a promising
compound is discovered, the two companies plan to conclude a commercialization
agreement.
Japan
Corporate News Network
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct